Evidence map›Paper›PMID 22214431›Full record

ArticleJournal of medicinal chemistry2012

Avenues for the development of therapeutics that target trace amine associated receptor 1 (TAAR1).

Gregory M Miller

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Trace Amine-Associated Receptor 1 Regulation of Methamphetamine Intake and Related Traits.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Gregory M MillerDivision of Neuroscience, New England Primate Research Center, Harvard Medical School, 1 Pine Hill Drive, Southborough, Massachusetts 01772, USA. gmiller@hms.harvard.edu

Funding

ZETA CHAIN OF T CELL RECEPTOR INTERACTS W/ NEF OF SIV &HIV2P51RR000168 · NCRR · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WESTMORELAND, SUSAN V. · 1985 to 2011
$139.3M
Drug Abuse-related Neurobiology and Genetic Variance Modeled in Rhesus MonkeysK02DA025697 · NIDA · HARVARD MEDICAL SCHOOL · PI MILLER, GREGORY MICHAEL · 2009 to 2013
$615k
MOUSE MODELS OF CANCER, BONE DISEASE, AND LACTATIONK26RR000168 · NCRR · OHIO STATE UNIVERSITY · PI ROSOL, THOMAS J · 2000 to 2004
$547k
NCRR NIH HHS K26 RR000168NCRR NIH HHS P51 RR000168NCRR NIH HHS RR00168NIDA NIH HHS DA025697NIDA NIH HHS K02 DA025697
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAutoreceptorsBrainCentral Nervous System StimulantsCyclic AMP-Dependent Protein KinasesHumansLymphocytesProtein Kinase CReceptors, Biogenic AmineReceptors, G-Protein-CoupledSignal TransductionTrace Amine-Associated ReceptorsVesicular Monoamine Transport ProteinsAutoreceptorsCentral Nervous System StimulantsCyclic AMP-Dependent Protein KinasesProtein Kinase CReceptors, Biogenic AmineReceptors, G-Protein-CoupledTrace Amine-Associated ReceptorsVesicular Monoamine Transport Proteins

Identifiers

PMID22214431
PMCPMC3618978

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.